Jean-Sebastien Frenel, Professor of Clinical Oncology at the Faculty of Medicine in Nantes University, shared French National Cancer Institute’s post on LinkedIn, adding:
“Thank you to French National Cancer Institute for this support, to the whole team ARCAGY-GINECO for this project resulting from our first brainstorming in 2025 and Institut de Cancérologie de l’Ouest (ICO) for the development and future implementation of this project.
Project co-sponsored with Julien Peron!”
Quoting French National Cancer Institute’s post:
“Results of the PHRC-K 2025-2026 call for projects: innovative clinical projects to improve cancer care
The Institut national du cancer announces the results of the call for projects of the Hospital Clinical Research Program in Cancer (PHRC-K), which funds clinical studies aimed at:
- Measure the effectiveness of health technologies,
- Assess their safety, tolerability and feasibility in humans.
In line with the ten-year strategy for the fight against cancer 2021-2030, this call for proposals pays particular attention to therapeutic de-escalation projects, in order to reduce the toxicity of treatments and limit the after-effects in the medium and long term, while preserving their effectiveness.
This year, 29 projects led by university hospitals, cancer centers and AP-HP throughout the country will be funded.
Congratulations to the winning teams and their partners for their commitment:
- CAUCACCE – Caroline Houillier (AP-HP)
- EsPhALL2022/AALL2131 – Virginie Gandemer (CHU de Rennes)
- RIO – Sophie Dugast (CHU de Nantes)
- SMART-EC – Jean-Sebastien FRENEL (Institut de Cancérologie de l’Ouest – ICO)
- EV-D – Cedric Pobel (Unicancer – Gustave Roussy)
- MATVAC-1 – Olivier Adotevi (Besançon University Hospital)
- HyPORT-01 – Gilles Créhange (Institut Curie)
- CLOSEorUP – Cecile LOAEC (Institut de Cancérologie de l’Ouest – ICO)
- UMBRELLA-THYME – Nicolas Girard (Institut Curie)
- PARADE – Corentin Orvain (CHU d’Angers )
- MARCH – Olivier Riou (Unicancer – ICM Montpellier)
- SOLARy – Eve Piekarski (AP-HP)
- LOTUS – Alejandra Martinez (Claudius Regaud Institute – IUCT-Oncopole)
- HER2low-Strategy – Benjamin Verret (Unicancer – Gustave Roussy)
- ACIKARE – Laurent MORTIER (Lille University Hospital)
- NEOLDER – Etienne BRAIN (Unicancer – Institut Curie)
- INTENSE-T4 – Vahan Képénékian (Hospices Civils de Lyon)
- ForInfantBB2 – Jean-Hugues Dalle (AP-HP)
- B2-ALK – David Sibon (AP-HP)
- INLIM – Caroline Knebelman-Robert (Gustave Roussy)
- GASTRINIP – smolenschi cristina (Unicancer – Gustave Roussy)
- HEROES-2 – Thibault de la Motte Rouge (Unicancer – Centre Eugène Marquis)
- FOCUS-SBRT – Mario Terlizzi (Unicancer – Gustave Roussy)
- MOTIVATE – Caroline EVEN (Unicancer – Gustave Roussy)
- TOCISARC – Jean-Yves Blay (Léon Bérard Centre)
- OPTIFU – Karim Bensalah (Rennes University Hospital)
- STRONG – Jean-Michel Lemée (Angers University Hospital)
- ALABATRE – Antoine Brouquet Greater Paris University Hospitals – AP-HP
- PREVENCE – Léa Guerrini-Rousseau (Gustave Roussy)
Find the details of the call for projects and all the results here
A program led by the INCa in connection with the Direction générale de l’offre de soins (DGOS) and the Ministère de la Santé”
Other articles about French National Cancer Institute on OncoDaily.